Overcome First Generation Gene Therapy Vector Challenges To Guarantee Targeted, Specific, Efficient & Safe Gene Delivery The 2nd Next Generation Gene Therapy Vectors Summit is dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors to deliver safe and efficacious gene therapy products. […]

LEAP HR: Life Sciences East 2022 Conference will be taking place as an in-person event in Boston, July 18-20. Returning as a physical event for its seventh year, this event will showcase 35+ case studies of how life sciences organizations of all stages and sizes are redefining post-pandemic best practices and turbocharging the employee experience […]

Cell Therapy Potency Assay Summit, taking place from 25-27 of July in Boston, will bring together professionals working in analytical development, quality, regulatory and process development functions. Join your peers to: Brainstorm best-in-class approaches to overcome variability in QC Compare next gen approaches from cytotoxicity to omics Develop reference standards to benchmark across the industry […]

The data has dropped and 2022 has been touted as a monumental year for γδT Therapies With Adicet Bio, In8Bio, Gamma Delta Therapeutics, Lava Therapeutics, and ImCheck Therapeutics releasing clinical data from engineered and antibody-based γδT Therapy in patients; the race to market for the first allogeneic and solid tumor-targeting γδT Therapy is truly on. […]

The 3rd Annual B & T Cell-Mediated Autoimmune Disease Drug Development Summit is the only industry-led forum focused on the therapeutic opportunity of drugs directed against B-cell, plasma cell, and T-cell targets in autoimmunity. Several drug approvals for B-cell directed therapies have made waves in autoimmune drug development. As investment and industry momentum increases, this […]

The 3rd Cytokine-Based Drug Development Summit has been developed following extensive research to address YOUR biggest challenges in the cytokine field. With 30+ expert speakers, including the hottest academic researchers and leading figures from the industry, this 4-day program is your opportunity to gain insight into the latest clinical advancement and have thought provoking discussions around how to overcome the […]

Do you want to be part of the largest gathering of mRNA professionals? The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28. Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content and 45+ deep-dive case studies. Find out more in the full event guide: https://ter.li/yc800m Here’s a snapshot of the expert speakers […]

With iPSCs exhibiting game-changing potential in the bid to develop an off-the-shelf therapy, the brand-new iPSC Manufacturing Summit is the only summit dedicated to solving the manufacturing, quality and analytical challenges hindering your iPSC-derived treatments from reaching patients. This forum will unite the exclusive community advancing the production of high-quality and consistent iPSC products, with in depth […]

The brand-new Targeted Radiopharmaceuticals Summit US (TRP US) is the only industry-led meeting dedicated to developing next-generation radioligands. The TRP sector has developed dramatically over the previous 18 months, with a wave of new investment in light of Lutathera’s extraordinary performance. Are you part of a pharmaceutical business aiming to have their Theranostic approved? If […]

Cell Therapy Analytical Development Summit Europe, taking place from 23-25 of August in London, will bring together professionals working in CMC, QC, process development, and regulatory functions. Join your peers in person to: Learn to develop a successful potency assay to determine product activity Explore reference standards for state-of-the-art analytical development Discover new technology to […]

With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater. From repairing and regenerating lung tissue to illuminating innovative clinical trial design and advance scientific progress; the 6th IPF Summit is your one-stop-shop to supercharge IPF research and drug development. […]

Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug to modify disease biology, which will be a game-changer for diseases such as oncology, autoimmune, and ophthalmology, with unmet medical needs. In collaboration with leading integrin drug developers, […]

Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development. Given the sheer volume of studies in the pipeline, the need to administer high doses, the clinical holds placed on gene therapy trials, and regulatory bodies being increasingly stringent on the safety standards they require; it has never been more […]

Over the last half-decade, we have witnessed game-changing developments within the cannabinoid field, driving it into a new era of rigorous research, promising clinical trials and multimillion-dollar deals. Right now, there are 50 cannabinoid therapeutic trials taking place at phases 2 and 3, pushing for approval to meet the clinical needs of patients with chronic […]

Revolutionizing Genetic Therapy Development & Delivery to the Eye Discovering Next Generation Administration Routes for the Eye; Overcoming the Translational Challenges of Ophthalmic Preclinical Models; & Discussing Toxicity & Targeting Challenges of Vector-Based Approaches The ophthalmology field is bursting with novel genetic approaches for targeting many disorders, with gene therapy taking centre stage as a […]

Translating Scientific Methodologies Addressing the Skin Microbiome into Commercially Viable Dermatological Therapeutics & Cosmetic Products Skin microbiome research is continuing to gain increasing market traction from a number of stakeholders, including drug developers and cosmetic brands. For investment and progress to continue, it is vital to meet and connect with the key opinion leaders in […]

Back to Boston with a bang! With 1,500 CAR and TCR developers, 200 speakers, 150 live presentations, 20 hours of networking and more surprises in store, the 7th CAR-TCR Summit will be the BIGGEST ever. Gain end-to-end insights from industry giants and the innovators bringing disruptive technologies from bench to bedside and from vein to vein. Discuss […]

2nd Annual Aseptic Processing Conference  Conference: 19 – 20 September 2022 Workshop: 21 September 2022 London, UK http://www.asepticprocessing.co.uk/PJWL Sponsored by: Dec Group, Rapid Micro Biosystems, Raumedic and STERIS Conference Chairman: James Drinkwater, Head of Aseptic Processing Special Interest Group PHSS and Head of GMP Compliance, F Ziel GMBH Driving a Holistic Approach to Assurance of Product Sterility through Aseptic […]

SAE Media Group’s 3rd Annual Conference September 19 - 20, 2022 | San Francisco, CA, USA ------------------------------------------------------------------------- The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. This year’s conference will be assessing the latest developments […]

The mRNA Process Development & Manufacturing Summit will be taking place in-person in Boston, MA this month (September 20 – 22, 2022). The only conference roadmap to accelerate mRNA drug substance process scale up and manufacturing! This conference will showcase the pioneering work of 30+ global leaders across 3 days of immersive content sharing new […]

Advances in molecular and immunohistochemical techniques have ushered the NSCLC space into an exciting era of personalized medicine and improved outcomes – and a plethora of novel therapies are now in clinical development. Despite this, and whether patients fit into one of the actionable alteration subtypes of NSCLC or not, most will progress and/or develop […]

Co-create a commercial toolkit that enables suitable, scalable and sustainable growth.  With over 20 CGTs projected to be approved by 2025, it’s clear that there are huge commercial and medical opportunities for precision medicine. But despite this unprecedented growth, unstable infrastructure, lack of standardization and novel scientific nuance means that there is still no industry […]

Part of the 13th annual RNA Therapeutic series of events SMi’s 2nd Annual Conference Oligonucleotide Therapeutics and Delivery Conference 2022 Date: 21st – 22nd September 2022 Location: London, UK Website: www.oligonucleotide.co.uk/PharmaJournalist Advancements in extra-hepatic delivery of oligonucleotides The Oligonucleotide Therapeutics and Delivery conference reveals the latest in oligonucleotide discovery and delivery, with presentations on targeted […]

For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible. Despite this, the first-ever FDA-approved KRAS G12C inhibitor has demonstrated that RAS is, in fact, druggable and that drugging this protein unlocks a world of successful therapeutic interventions. The future looks bright for treating patients with cancers harboring the […]

The Definitive Event to Transform Your Internal Impact & Differentiate Your Employer Brand to Attract the in-Demand Biopharma Talent Required to Fast-Track Business Innovation & Growth Now in its fourth year, LEAP TA: Life Sciences is the only forum dedicated to helping established and emerging life sciences organizations operating in the US who are breaking […]

Uniting industry experts dedicated to accelerating the frontier of transformative therapeutics, the 2nd Rare & Genetic Kidney Disease Drug Development Summit is the definitive industry forum sharing cross-industry insight to understand genetic drivers of disease, uncover early biomarkers of efficacy, and navigate disease specific endpoint development. From clarifying molecular characteristics to reclassify disease subtypes to enrolling patient […]

4th Macrophage-directed Therapies Summit, taking place from 4-6 of October in Boston, will bring together professionals to accelerate the clinical validation of macrophage-directed therapies, manipulating and fixing phenotypic plasticity to develop safe, targeted therapies for oncology, autoimmunity, inflammation and beyond. Join your peers in person and delve into: CD47 targeting and other ‘don’t eat me’ signals […]

2nd Annual Next Generation Pharmaceutical Cleanroom 5 – 6 October 2022 London, UK http://www.nextgen-pharmacleanroom.com/PJwl Sponsored by Ecolab, Elis Cleanroom, Innerspace, Microgenetics, Novatek Co-Chaired by: Conor Murray, Chairman, Irish Cleanroom Society and Connor McMorrow, Aseptic Lead Cell Therapy, Takeda  Advances in Pharma 4.0 for an Improved, Efficient and Contaminant-Free Cleanroom SAE Media Group are pleased to announce the 2nd Annual Next […]

SAE Media Group's 3rd Annual Wearable Injectors and Connected Devices Conference 10 – 11 October 2022 | London, UK http://www.wearable-injectors.co.uk/Pharmajournalist The Latest Innovations In Digital Health And On-Body Drug Delivery For The Pharmaceutical Industry SAE Media Group’s 3rd annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging […]

Comprehensive frameworks for equitable access and accelerated digital transformations are soon to be realized. But progress is slowing, risking a return to the old model plagued by persistent health disparities. To thrive, each strategy and tactic must be centred with a whole-human approach, ensuring an agile, patient-driven, technology-enabled change. You must advance intelligent automation, delivering […]